Dr. Reddy's

Few pharmaceuticals players in Asia Pacific match the executional depth of Dr. Reddy's. From Hyderabad, the group manages a workforce of approximately 26k and generates close to $3B in revenue, while steadily widening the gap with regional peers.

Long-term partnerships with sovereign and institutional investors give the company unusual visibility on multi-year demand.

“Dr. Reddy's is, in its category, exactly the kind of compounding regional champion the next decade of capital allocation will reward.”

Analysts increasingly view the group as a regional bellwether — its quarterly trajectory tends to anticipate sector-wide moves.